Jan 02, 2020
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets
Nov 18, 2019
California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA(TM) Awards for the Deal of the Year
Oct 31, 2019
Arena Pharmaceuticals to Release Third Quarter 2019 Financial Results and Provide Corporate Update on November 7
Oct 28, 2019
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis
Oct 22, 2019
Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week
Oct 18, 2019
Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community
Sep 26, 2019
Arena Pharmaceuticals Presented New Data from the Phase 2 OASIS trial for Etrasimod at the World Congress of Gastroenterology Meeting
Sep 09, 2019
Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting
Aug 28, 2019
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 07, 2019
Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials
Jul 31, 2019
Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7
Jun 13, 2019
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
May 17, 2019
Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community
May 13, 2019
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
May 08, 2019
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2019 Financial Results
May 01, 2019
Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8
Apr 03, 2019
Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10
Mar 08, 2019
Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation
Feb 26, 2019
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
Feb 07, 2019
Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress